NASDAQ: HCPHashicorp Inc Stock
$32.76-0.05 (-0.15%)
Updated May 9, 2024
HCP Price
$32.76
Fair Value Price
-$29.05
Market Cap
$6.54B
52 Week Low
$18.91
52 Week High
$36.39
P/E
-33.43x
P/B
5.39x
P/S
7.27x
PEG
N/A
Dividend Yield
N/A
Revenue
$583.14M
Earnings
-$190.67M
Gross Margin
81.4%
Operating Margin
-32.52%
Profit Margin
-32.7%
Debt to Equity
0.4
Operating Cash Flow
-$11M
Beta
2.45
Next Earnings
Jun 28, 2024
Ex-Dividend
N/A
Next Dividend
N/A
HCP Overview
HashiCorp, Inc. is a freemium software company that offers open-source tools and commercial products that enable developers, operators, and security professionals to provision, secure, run and connect cloud-computing infrastructure. HashiCorp's main product line consists of Vagrant, Packer, Terraform, Consul, Vault, Nomad, Serf, Sentinel, Boundary, and Waypoint. The company was founded in 2012 and is based in San Francisco, CA.
Zen Score
–
Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how HCP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HCP ($32.76) is overvalued by 212.77% relative to our estimate of its Fair Value price of -$29.05 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
HCP ($32.76) is not significantly undervalued (212.77%) relative to our estimate of its Fair Value price of -$29.05 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
HCP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more HCP due diligence checks available for Premium users.
Be the first to know about important HCP news, forecast changes, insider trades & much more!
HCP News
Valuation
HCP fair value
Fair Value of HCP stock based on Discounted Cash Flow (DCF)
Price
$32.76
Fair Value
-$29.05
Undervalued by
212.77%
HCP ($32.76) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HCP ($32.76) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HCP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
HCP price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-33.43x
Industry
43.42x
Market
29.92x
HCP price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.39x
Industry
11.38x
HCP is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
HCP's financial health
Profit margin
Revenue
$155.8M
Net Income
-$31.6M
Profit Margin
-20.3%
HCP's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
HCP's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.7B
Liabilities
$479.0M
Debt to equity
0.4
HCP's short-term assets ($1.54B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HCP's short-term assets ($1.54B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HCP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$10.3M
Investing
$12.9M
Financing
$10.4M
HCP's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
HCP vs Software Infrastructure Stocks
Hashicorp Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.